Influence of systemic propranolol treatment on the physical development of pediatric patients with infantile hemangiomas

Int J Dermatol. 2023 Mar;62(3):e137-e138. doi: 10.1111/ijd.16368. Epub 2022 Aug 10.

Authors

Jianyong Dong^{1

2}, Huimin Rong³, Zuoqing Dong¹, Anwei Chen¹, Tao Wang¹, Shaohua Liu¹

Affiliations

¹ Department of Oral and Maxillofacial Surgery, Qilu Hospital and Institute of Stomatology, Shandong University, Jinan, Shandong, China.
² Gao Xin Branch, Jinan Stomatological Hospital, Jinan, Shandong, China.
³ School of Medicine, Shandong University, Jinan, Shandong, China.

PMID: 35949165
DOI: 10.1111/ijd.16368

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Oral
Adrenergic beta-Antagonists / therapeutic use
Child
Hemangioma, Capillary*
Humans
Infant
Propranolol / therapeutic use
Skin Neoplasms* / drug therapy
Treatment Outcome

Substances

Propranolol
Adrenergic beta-Antagonists

Grants and funding